Author(s):
Ramaekers, V.T. 
; Sequeira, J.M. ; Artuch, R. ; Blau, N. ; Temudo, T. ; Ormazabal, A. ; Pineda, M. ; Aracil, A. ; Roelens, F. ; Laccone, F. ; Quadros, E.V.
Date: 2007
Persistent ID: http://hdl.handle.net/10400.16/433
Origin: Repositório Científico do Centro Hospitalar do Porto
Description
Neuropediatrics. 2007 Aug;38(4):179-83.
Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome.
Ramaekers VT, Sequeira JM, Artuch R, Blau N, Temudo T, Ormazabal A, Pineda M, Aracil A, Roelens F, Laccone F, Quadros EV.
Division of Pediatric Neurology, University Hospital Aachen, Germany. vramaekers@skynet.be
Abstract
Rett syndrome was associated with low cerebrospinal fluid (CSF) 5-methyltetrahydrofolate (5MTHF) in 42-50% of European patients whereas approximately 93% of the patients from North-America had a normal CSF 5MTHF status. We determined the CSF folate status in Rett patients living in North- and South-Western Europe and measured serum folate receptor (FR) autoantibodies of the blocking type to explain the reduced folate transport across the choroid plexus. Irrespective of their MECP2 genotype and despite normal plasma folate values, 14 of 33 Rett patients (42%) had low CSF folate levels. Blocking FR autoantibodies were found in 8 of the Rett patients (24%), 6 of whom had low CSF folate levels. FR autoimmunity was primarily found within the group of Rett patients with low CSF folate status with a higher incidence in North-Western Europe. In Rett patients from North-America 74 of 76 girls had higher folate values in both serum and CSF than European patients. The food folate fortification in North-America may account for the higher folate levels and may prevent CFD in these Rett patients. FR autoimmunity occurred predominantly in Rett patients from North-Western Europe and may contribute to cerebral folate deficiency (CFD).
PMID: 18058624 [PubMed - indexed for MEDLINE]
